C4 Therapeutics, Inc. (CCCC)
NASDAQ·Healthcare·Biotechnology
$2.74
-3.18%
Mkt Cap $234.40M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $5.39M | $11.02M | +104.20% | -$0.31 | -$0.18 | +41.94% | — | — |
| Q4 2025 Nov 6, 2025 | $4.48M | $11.23M | +150.67% | -$0.47 | -$0.44 | +6.38% | — | — |
| Q3 2025 Aug 7, 2025 | $6.80M | $6.46M | -4.96% | -$0.38 | -$0.37 | +2.63% | — | — |
| Q2 2025 May 7, 2025 | $3.54M | $7.24M | +104.46% | -$0.48 | -$0.37 | +22.92% | — | — |
| Q1 2025 Feb 27, 2025 | $3.33M | $5.18M | +55.31% | -$0.44 | -$0.49 | -11.36% | — | — |
| Q4 2024 Oct 31, 2024 | $3.33M | $15.36M | +360.86% | -$0.40 | -$0.35 | +12.50% | — | — |
| Q3 2024 Aug 1, 2024 | $4.78M | $12.01M | +151.00% | -$0.37 | -$0.26 | +29.73% | — | — |
| Q2 2024 May 8, 2024 | $8.10M | $3.04M | -62.48% | -$0.41 | -$0.41 | +0.00% | — | — |
| Q1 2024 Feb 22, 2024 | $3.19M | $3.26M | +2.23% | -$0.67 | -$0.68 | -1.49% | — | — |
| Q4 2023 Nov 1, 2023 | $5.46M | $11.07M | +102.78% | -$0.65 | -$0.55 | +15.38% | — | — |
| Q3 2023 Aug 8, 2023 | $6.44M | $2.66M | -58.63% | -$0.74 | -$0.73 | +1.35% | — | — |
| Q2 2023 May 4, 2023 | $5.46M | $3.76M | -31.15% | -$0.78 | -$0.71 | +8.97% | — | — |
| Q1 2023 Feb 23, 2023 | $9.87M | $2.85M | -71.09% | -$0.72 | -$0.76 | -5.56% | — | — |
| Q4 2022 Nov 3, 2022 | $8.45M | $6.75M | -20.07% | -$0.65 | -$0.65 | +0.00% | — | — |
| Q3 2022 Aug 4, 2022 | $7.64M | $13.83M | +81.13% | -$0.68 | -$0.56 | +17.65% | — | — |
| Q2 2022 May 5, 2022 | $7.81M | $7.65M | -1.94% | -$0.61 | -$0.65 | -6.56% | — | — |
| Q1 2022 Feb 24, 2022 | $7.41M | $20.08M | +171.02% | -$0.59 | -$0.31 | +47.46% | — | — |
| Q4 2021 Nov 10, 2021 | $9.78M | $8.50M | -13.04% | -$0.60 | -$0.51 | +15.00% | — | — |
| Q3 2021 Aug 11, 2021 | $6.02M | $9.78M | +62.48% | -$0.60 | -$0.51 | +15.00% | — | — |
| Q2 2021 May 13, 2021 | $9.08M | $7.43M | -18.18% | -$0.63 | -$0.49 | +22.22% | — | — |